Eficácia e aderência à suplementação de vitamina D em pacientes com doença de Crohn em remissão e Hipovitaminose D: estudo piloto de um ensaio clínico randomizado, duplo-cego, placebo-controlado
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Crohn's disease (CD) is an immune-mediated inflammatory bowel disease. It is known
that vitamin D plays a role in regulating the immune response and helps maintain
musculoskeletal integrity. Patients with CD often have low serum vitamin D levels. The
present study aims to evaluate the effect of vitamin D supplementation on muscle
strength and fatigue in patients with CD and D hypovitaminosis. Secondarily, it will also
be observed if the dose of 50,000 IU / weekly of vitamin D is well tolerated and capable
of raising serum vitamin D levels (25-OH-D) in the patients studied.
This was a pilot study involving 10 patients from a current, double-blind, randomized,
placebo-controlled clinical trial, which will comprise a sample of 110 patients with CD
in remission. Patients were randomly allocated into two groups: weekly doses of
50,000 IU of vitamin D or placebo for 6 months. Muscle strength was assessed by
manual dynamometry and self-reported fatigue using the Chalder questionnaire taken
before and at the end of the 6th month after the intervention. Weekly contacts were
conducted via telephone to assess adverse effects and tablet counts at 3-month
intervals to assess adherence.
All patients remained in remission until completion of the study. No adverse effects
were reported and adherence to vitamin D supplementation was observed. Vitamin D
levels reached values within the lower limits of normality, but the increase in muscle
strength in the test group was not observed. In this group, two patients (100%) with
fatigue in the inclusion obtained a reversion of fatigue after the intervention.
The vitamin D replacement protocol was well tolerated and generated good adherence
in the study population. This intervention elevated serum levels of vitamin D, but was
unable to generate increased muscle strength, although it produced reduced fatigue
symptoms. These preliminary findings suggest a possible benefit of vitamin D for the
treatment of fatigue in CD, which should be confirmed with the increase in the
casuistry.
ClinicalTrials.gov Identifier NCT02704624. Date of registration: 02/24/2016.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
